KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Advicenne CEO updates on Phase III rare disease program

Advicenne's CEO Luc-André Granier talks to Scrip about the development journey of its Phase III pediatric-friendly product for a rare renal disease and the differences involved when creating a product for use across various age groups. He also discusses the company's recent IPO and his future vision for the business.

Get the latest news as it happens.